(Q44279121)

1 December 2017

0 references

Endogenous cannabinoids: a new target in the treatment of obesity (English)

1 reference

1 December 2017

0 references

0 references

Tim C Kirkham

1

1 reference

PubMed ID

12529283

1 December 2017

language of work or name

1 reference

1 February 2003

1 reference

American Journal of Physiology - Regulatory, Integrative and Comparative Physiology

1 December 2017

1 reference

1 December 2017

284

1 reference

1 December 2017

R343-4

1 reference

1 December 2017

2

1 reference

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors.

1 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Leptin-regulated endocannabinoids are involved in maintaining food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Synergistic efects of opioid and cannabinoid antagonists on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Recent clinical experience with dronabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Hyperphagia in pre-fed rats following oral delta9-THC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

Observational analysis of feeding induced by Delta9-THC and anandamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPREGU.00706.2002

10.1152/AJPREGU.00706.2002

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference

PubMed ID

12529283